AstraZeneca to invest over 3.6 mln euro in clinical trials in Bulgaria in 2014
Pharmaceuticals company AstraZeneca plans to invest over 7.0 million levs ($4.9 million/3.6 million euro) in clinical trials in Bulgaria ...
Pharmaceuticals company AstraZeneca plans to invest over 7.0 million levs ($4.9 million/3.6 million euro) in clinical trials in Bulgaria ...
More than $10 million have been invested in a program of clinical reserches on biotech drugs for the last five years in Bulgaria
More than $10 million have been invested in a program of clinical reserches on biotech drugs for the last five years in Bulgaria. That was pointed out by Dr. Krasimira Chemishanska, CEO “Amgen Bulgaria” at the science conference “ Innovations in the biotechs – the future medicine” held in Sofia on 31th October.
Dr. Chemishanska explained that the development of a single drug is a huge investment of time and financial resources as well as is associated with a significant risk for manufacturer. Between 10 to 15 years takes the development process and the investment could exceed 1 billion dollars.
Source: investor.bg
Photo: cross.bg
Българска Агенция за Инвестиции
Ул. Врабча ет.3 23, София 1000
Тел.: ( +359 2 ) 985-5500
Факс: ( +359 2 ) 980-1320
Е-mail: iba@investbg.government.bg
InvestBulgaria Agency
23 Vrabcha fl. 3 Street
Sofia 1000, Bulgaria
Tel.: ( +359 2 ) 985-5500
Fax: ( +359 2 ) 980-1320
E-mail: iba@investbg.government.bg